Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Acta Oncologica (Stockholm, Sweden)|September 5, 2015
NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapyAnnika Jakobi, Kristin Stützer, Anna Bandurska-Luque, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
Theranostics|August 8, 2024
68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Cancers|October 2, 2020
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast CancersAadhya Tiwari, Mari Iida, Corinna Kosnopfel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2025
Radiobiology and Radioresistance in High-Dose Radiosurgery for Brain Tumors: A Hypothesis-Generating Study Using an Intracranial Glioma Mouse ModelAnastasia Janas, Carolin Senger, Kiril Krantchev, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 29, 2021
Radiotherapy in nodal oligorecurrent prostate cancerMichael Pinkawa, Daniel M Aebersold, Dirk Böhmer, et al.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
PET/MRI and genetic intrapatient heterogeneity in head and neck cancersKerstin Clasen, Sara Leibfarth, Franz J Hilke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 1, 2019
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancerMarcus Beck, Dirk Böhmer, Daniel M Aebersold, et al.
The Oncologist|April 1, 2017
Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed GlioblastomaMarco Skardelly, Elena Dangel, Julia Gohde, et al.
Pageof 30